Praxis Precision Medicines Inc. is set to report second-quarter results, with investors focused on cash burn and commercial readiness as the company awaits two key FDA drug approval decisions. Analysts have a strong buy rating with significant upside potential. The company's cash runway and …
Triple Flag Precious Metals Corp. is preparing to report second-quarter earnings, with analysts expecting a sequential decline in revenue but robust year-over-year growth. The company's "transition year" status and recent acquisition of a gold stream on Australia's Ravenswood mine are key areas of investor …
VPG's Sensors segment led strong growth and record bookings, with revenue up 12% year-over-year despite shipment delays and FX headwinds. The company expects full-year organic growth to surpass targets due to robust demand in AI and robotics. This information is based on Vishay Precision …
CoreCivic has successfully sold its Prairie Correctional Facility and Midwest Regional Reception Center to the U.S. government for $734 million, expecting net proceeds of $522.5 million. The company plans to use these proceeds for general corporate purposes, including potential debt reduction and stock repurchases. …
CoreCivic, Inc. Follows Sales of Two Detention Facilities in California BRENTWOOD, Tenn., Aug. 05, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) (CoreCivic or the Company) announced today that it has completed the sales of its 1,600-bed Prairie Correctional Facility in Appleton, Minnesota and …
Vishay Precision Group, Inc. (VPG) reported Q2 adjusted EPS of $0.04 per share, significantly missing the FactSet estimate of $0.19. The company also reported Q2 revenue of $83.9 million, which was below the FactSet estimate of $87.4 million. Following these results, Vishay Precision Group's …
VISHAY PRECISION GROUP ($VPG) reported its Q2 2026 earnings, missing both earnings per share and revenue estimates. The company posted earnings of $0.04 per share against an estimate of $0.19, and revenue of $83.94 million compared to an estimated $85.49 million. The article also …
* Vishay Precision press release [https://seekingalpha.com/pr/20607343-vpg-reports-fiscal-2026-second-quarter-results-orders-of-96-million-reflect-continued] (VPG [https://seekingalpha.com/symbol/VPG]): Q2 Non-GAAP EPS of $0.04 misses by $0.15. * Revenue of $83.9M (+11.6% Y/Y) misses by $3.54M. * Adjusted EBITDA was $5.5 million with an adjusted EBITDA margin of 6.5%. * Adjusted gross profit margin was …
Vishay Precision Group (VPG) announced its fiscal Q2 2026 results, reporting net revenues of $83.9 million, an 11.7% increase year-over-year, and bookings of $95.5 million with a book-to-bill ratio of 1.14. Despite strong order momentum, including record orders for precision resistors and a vendor …
PRECIGEN, INC. (PGEN) reported strong results for the quarter ending 2026, with revenue reaching $54.98 million and diluted EPS at $0.05, significantly improving from the prior year. This growth was primarily driven by the successful commercial launch of Papzimeos, following its FDA approval in …
HC Wainwright & Co. has reiterated its Buy rating for Precigen, maintaining a price target of $14.00 per share. This indicates continued analyst confidence in the company's stock performance.
Analysts have significantly downgraded their revenue forecasts for Precision BioSciences, Inc. (NASDAQ:DTIL) for 2026, now expecting US$13m, a 72% decline, and increased their loss per share estimates to US$2.96. This revised outlook reflects a more conservative view, predicting the company's revenue will decline at …
Wheaton Precious Metals Corp has acquired a 7.37% voting interest in KGL Resources Limited, becoming a substantial holder. This acquisition involved 167,500,000 ordinary shares at A$0.20 each, totaling A$33,500,000, as part of a conditional placement announced by KGL on June 25, 2026. Wheaton's relevant …
This article analyzes Precipio Inc. (NASDAQ: PRPO) using AI models to generate trading strategies across different risk profiles. Key findings indicate divergent sentiment, suggesting choppy conditions, and highlights support and resistance levels. The analysis provides specific entry, target, and stop-loss zones for position trading, …
Wheaton Precious Metals WPM is scheduled to report second-quarter 2026 results on Aug. 6, after market close. The Zacks Consensus Estimate for Wheaton Precious Metals' second-quarter sales is pegged at $877 million, indicating 74% growth from the prior-year quarter's reported figure. The consensus mark …
WPM
main company
WPM
main company
WPM
main company
CoreCivic (NYSE:CXW) has secured a five-year contract with U.S. Immigration and Customs Enforcement (ICE) to reactivate its 1,600-bed Prairie Correctional Facility in Appleton, Minnesota, which has been idle since 2010. The contract, effective August 11, 2026, is expected to generate approximately $75 million in …
ICE and private prison company CoreCivic will reopen the 1,600-bed Prairie Correctional Facility in Appleton, Minnesota, as an immigrant detention center, with operations expected to begin in the fourth quarter of 2026. The contract is valued at over $536 million over five years, with …
Precigen, Inc. has released its earnings summary for the quarter that concluded on June 30. The article is from Refinitiv and is hosted on TradingView, which also offers access to news from Reuters and other sources.
* Precigen press release [https://seekingalpha.com/pr/20606749-precigen-reports-second-quarter-2026-financial-results-highlighted-by-accelerating-papzimeos] (PGEN [https://seekingalpha.com/symbol/PGEN]): Q2 GAAP EPS of $0.05 beats by $0.06. * Revenue of $54.98M beats by $27.15M. MORE ON PRECIGEN * Precigen: Entering The Oncology 'Sweet Spot' [https://seekingalpha.com/article/4918147-precigen-entering-the-oncology-sweet-spot] * Precigen, Inc. (PGEN) Presents at Goldman Sachs 47th Annual Global …
Precigen announced strong second-quarter 2026 financial results, driven by accelerated revenue growth from its PAPZIMEOS treatment, which generated $53.1 million. The company achieved quarterly profitability and expects to reach cash flow break-even by the end of 2026, supported by broad U.S. adoption, seven-year market …
Praxis Precision Medicines (PRAX) announced the grant of restricted stock unit (RSU) awards covering 7,318 common shares to 29 new non-executive employees. These inducement grants, made under the 2024 Inducement Plan and Nasdaq Listing Rule 5635(c)(4), will vest in four equal annual installments, contingent …
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.